Find similar content

Source channel @githubtrending · Post #14869 · Jun 26

#html#data_science#education#machine_learning#machine_learning_algorithms#machinelearning#machinelearning_python#microsoft_for_beginners#ml#python#r#scikit_learn#scikit_learn_python Microsoft’s "Machine Learning for Beginners" is a free, 12-week course with 26 lessons designed to teach classic machine learning using Python and Scikit-learn. It includes quizzes, projects, and assignments to help you learn by doing, with lessons themed around global cultures to keep it engaging. You can access solutions, videos, and even R language versions. The course is beginner-friendly, flexible, and helps build practical skills step-by-step, making it easier to understand and apply machine learning concepts in real-world scenarios. This structured approach boosts your learning retention and prepares you for further study or career growth in ML[1][5]. https://github.com/microsoft/ML-For-Beginners

Hashtags

#html #data_science #education #machine_learning #machine_learning_algorithms #machinelearning #machinelearning_python #microsoft_for_beginners #ml #python #r #scikit_learn #scikit_learn_python

Results

2 similar posts found

Search: #drugdevelopment

当前筛选 #drugdevelopment清除筛选

Crypto M - Crypto News

@CryptoM · Post #64470 · 04/09/2026, 01:45 AM

Find similar View

🚀 Hong Kong's Innovative Drug Sector Gains Momentum Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends. #HongKong#Pharmaceuticals#Biotech#Innovation#StockMarket#Healthcare#DrugDevelopment

Hashtags

#hongkong #pharmaceuticals #biotech #innovation #stockmarket #healthcare #drugdevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 12/21/2024, 10:23 AM

Find similar View

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment

Hashtags

#biotech #funding #cancer #immunedisorders #california #clinicalstage #therapies #investment #healthcare #innovation #pepromenebio #pharmaceuticals #medicalresearch #drugdevelopment